11:29 AM EDT, 07/15/2024 (MT Newswires) -- Edwards Lifesciences ( EW ) said Monday it has exercised its option to acquire heart valve device maker Innovalve Bio Medical following its initial investment in 2017.

The acquisition, which will likely close by the end of the year, is expected to support Edwards' transcatheter mitral valve replacement services, the company said.

Financial details were not disclosed.

Price: 89.95, Change: -1.04, Percent Change: -1.14